Trends in hospital price transparency after implementation of the CMS Final Rule
Health Services Research · 2024-08 · 59 (4)
DOI: 10.1111/1475-6773.14329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Services Research, online erschienen am 28.05.2024. Verfasst von Aaron Brant und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA. Hauptthemen laut MEDLINE: Centers for Medicare and Medicaid Services, U.S., Disclosure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To assess trends in hospital price disclosures after the Centers for Medicare & Medicaid Services (CMS) Final Rule went into effect. Data Sources and Study Setting The Turquoise Health Price Transparency Dataset was used to identify all US hospitals that publicly displayed pricing from 2021 to 2023. Study Design Price‐disclosing versus nondisclosing hospitals were compared using Pearson's Chi‐squared and Wilcoxon rank sum tests. Bayesian structural time‐series modeling was used to determine if enforcement of increased penalties for nondisclosure was associated with a change in the trend of hospital disclosures. Data Collection/Extraction Methods Not applicable. Principal Findings As of January 2023, 5162 of 6692 (77.1%) US hospitals disclosed pricing of their services, with the majority (2794 of 5162 [54.1%]) reporting their pricing within the first 6 months of the final rule going into effect in January 2021. An increase in hospital disclosures was observed after penalties for nondisclosure were enforced in January 2022 (relative effect size 20%, p = 0.002). Compared with nondisclosing hospitals, disclosing hospitals had higher annual revenue, bed number, and were more likely to be have nonprofit ownership, academic affiliation, provide emergency services, and be in highly concentrated markets ( p < 0.001).
Conclusions
Hospital pricing disclosures are continuously in flux and influenced by regulatory and market factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA.
- Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
ORCID-Profile: Aaron Brant
Zitieren
APA
Brant, A., Lewicki, P., Rhodes, S., Zhu, A., & Shoag, J. (2024). Trends in hospital price transparency after implementation of the CMS Final Rule. Health Services Research, 59(4). https://doi.org/10.1111/1475-6773.14329
Vancouver
Brant A, Lewicki P, Rhodes S, Zhu A, Shoag J. Trends in hospital price transparency after implementation of the CMS Final Rule. Health Services Research. 2024;59(4). doi:10.1111/1475-6773.14329
BibTeX
@article{Brant2024,
author = {Brant, Aaron and Lewicki, Patrick and Rhodes, Stephen and Zhu, Alec and Shoag, Jonathan},
title = {Trends in hospital price transparency after implementation of the CMS Final Rule},
journal = {Health Services Research},
year = {2024},
volume = {59},
number = {4},
doi = {10.1111/1475-6773.14329}
}
EUVIMED